ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,142Medicare Part D Prescriptions Filled, Including Refills

Rank: 88 out of 676

$1.01M Total Retail Price of All Prescriptions

Rank: 55 out of 676

1,324 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 1,324 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

11% of this provider’s 1,324 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 12,931 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
HYDROCODONE-ACETAMINOPHEN 756 492 S3 1 1
ZOSTAVAX 674 623 2 117
OMEPRAZOLE 622 481 3 2
AMLODIPINE BESYLATE 612 548 4 3
GABAPENTIN 440 301 5 10
FUROSEMIDE 387 328 6 4
LEVOTHYROXINE SODIUM 368 283 7 7
LISINOPRIL 357 322 8 5
SIMVASTATIN 334 285 9 6
WARFARIN SODIUM 302 293 10 18
POTASSIUM CHLORIDE 253 233 11 9
TRAMADOL HCL 253 184 11 19
PRAVASTATIN SODIUM 227 158 13 11
ZOLPIDEM TARTRATE 225 141 14 21
METOPROLOL SUCCINATE 221 157 15 14
DONEPEZIL HCL 204 203 16 24
SERTRALINE HCL 199 151 17 26
METFORMIN HCL 197 116 18 8
METOPROLOL TARTRATE 180 144 19 22
CITALOPRAM HBR 166 149 20 17
CARVEDILOL 165 144 21 15
VENLAFAXINE HCL ER 162 116 22 98
ATORVASTATIN CALCIUM 159 132 23 20
FENTANYL 146 105 S2 24 93
LOSARTAN POTASSIUM 141 131 25 34
CYMBALTA 133 38 26 47
DIOVAN 128 99 27 37
NAMENDA 126 126 28 35
RANITIDINE HCL 125 92 29 27
MIRTAZAPINE 124 90 30 59
POLYETHYLENE GLYCOL 3350 121 104 31 56
PANTOPRAZOLE SODIUM 121 80 31 42
LISINOPRIL-HYDROCHLOROTHIAZIDE 115 80 33 16
AMITRIPTYLINE HCL 111 52 R 34 46
ALLOPURINOL 111 97 34 31
DIOVAN HCT 110 84 36 41
CLOPIDOGREL 106 94 37 28
CRESTOR 105 71 38 29
NEXIUM 103 72 39 23
JANUVIA 102 86 40 78
MORPHINE SULFATE ER 101 33 S2 41 131
FLUTICASONE PROPIONATE 94 77 42 49
LANTUS 94 84 42 55
TRAZODONE HCL 94 62 42 36
LOVASTATIN 93 77 45 33
MELOXICAM 93 68 45 13
PREDNISONE 92 74 47 53
LYRICA 85 27 48 57
HYDROCHLOROTHIAZIDE 84 73 49 12
ROPINIROLE HCL 84 58 49 85
PLAVIX 81 71 51 40
CLONIDINE HCL 79 63 52 32
TIZANIDINE HCL 77 26 53 68
ZETIA 74 53 54 89
CEFUROXIME 73 59 55 121
PROAIR HFA 70 26 56 79
CIPROFLOXACIN HCL 68 56 57 45
ATENOLOL 68 51 57 25
TOPIRAMATE 68 29 57 141
TAMSULOSIN HCL 68 62 57 38
GLIMEPIRIDE 67 61 61 30
PROMETHAZINE HCL 64 26 R 62 75
AMLODIPINE BESYLATE-BENAZEPRIL 63 42 63 44
AZITHROMYCIN 62 50 64 39
ENDOCET 61 48 S2 65 104
RISPERIDONE 60 42 66 69
TERAZOSIN HCL 60 47 66 145
LEVOFLOXACIN 60 41 66 91
NAPROXEN 58 50 69 71
METHOCARBAMOL 57 34 R 70 163
METOCLOPRAMIDE HCL 57 43 70 107
SPIRIVA 57 55 70 97
PRADAXA 56 56 73 300
HALOPERIDOL 56 53 73 158
OXYCODONE HCL-ACETAMINOPHEN 55 24 S2 75 139
NOVOLOG 54 32 76 134
LEVEMIR FLEXPEN 54 33 76 192
QUETIAPINE FUMARATE 54 14 76 72
DIGOXIN 53 46 79 52
BACLOFEN 53 29 79 144
DOXYCYCLINE HYCLATE 52 36 81 82
JANTOVEN 52 39 81 156
NOVOLIN N 52 42 81 239
FLUCONAZOLE 51 33 84 115
OLANZAPINE 50 45 85 125
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 2, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.